Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Kidswell Bio Corporation (4584) Stock Price & Analysis

0 Followers

4584 Stock Chart & Stats

¥146.00-¥4.00(-2.67%)
At close: 3:30 PM GMT+9
¥150¥160¥170¥180Aug 10Aug 24Sep 7Sep 18Oct 5Oct 19Nov 2
Day’s Range
JPY 145.00 - JPY 156.00
52-Week Range
JPY 125.00 - JPY 320.00
Previous Close
JPY 150.00
Volume
N/A
Average Volume (3M)
219.23K
Market Cap
JPY 7.59B
Enterprise Value
JPY 6.45B
Total Cash (Recent Filing)
JPY 3.23B
Total Debt (Recent Filing)
JPY 2.48B
Price to Earnings (P/E)
―
Beta
1.14
Next Earnings
Nov 12, 2026 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Revenue Scale

The substantial increase in revenue indicates that Kidswell Bio has expanded its commercial scale over several years. A larger revenue base can support broader development activity, improve operating leverage over time, and provide a stronger platform for future biopharmaceutical commercialization.

Positive Gross Margin

Maintaining a positive gross margin shows that the company’s revenue currently contributes toward covering operating costs rather than being entirely offset by direct costs. This provides an underlying economic base that could support improved profitability if operating efficiency and revenue mix strengthen.

Improved Equity Position

The recovery in equity and reduction in debt-to-equity from the 2024 level indicate some balance-sheet repair over the period. Although leverage remains meaningful, this improvement provides a stronger capital base and somewhat more financial resilience than at the earlier low point.

Bears Say

Persistent Unprofitability

The return to operating and net losses after near break-even results in 2025 demonstrates that profitability is not yet durable. Continued earnings volatility can restrict internally funded investment, weaken financial flexibility, and make sustained biopharmaceutical development more dependent on external funding.

Cash Burn

The sharp reversal from positive operating and free cash flow in 2025 to substantial cash burn in 2026 shows that cash generation is unstable. Repeated negative operating cash flow can reduce funding flexibility and increase reliance on financing while the company continues development activities.

Elevated Leverage

Leverage remains high for a company that is not consistently profitable, and negative returns on equity indicate that capital is not currently producing adequate earnings. Debt obligations can constrain future investment capacity and heighten refinancing pressure during periods of cash burn.

Kidswell Bio Corporation News

4584 FAQ

What was Kidswell Bio Corporation’s price range in the past 12 months?
Kidswell Bio Corporation lowest stock price was ¥125.00 and its highest was ¥320.00 in the past 12 months.
What is Kidswell Bio Corporation’s market cap?
Kidswell Bio Corporation’s market cap is ¥7.59B.
When is Kidswell Bio Corporation’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Kidswell Bio Corporation’s earnings last quarter?
Kidswell Bio Corporation released its earnings results on Aug 13, 2026. The company reported ¥3.99 earnings per share for the quarter.
Is Kidswell Bio Corporation overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Kidswell Bio Corporation pay dividends?
Kidswell Bio Corporation does not currently pay dividends.
What is Kidswell Bio Corporation’s EPS estimate?
Kidswell Bio Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Kidswell Bio Corporation have?
Kidswell Bio Corporation has 50,604,187 shares outstanding.
What happened to Kidswell Bio Corporation’s price movement after its last earnings report?
Kidswell Bio Corporation reported an EPS of ¥3.99 in its last earnings report. Following the earnings report the stock price went up 2.703%.
Which hedge fund is a major shareholder of Kidswell Bio Corporation?
Currently, no hedge funds are holding shares in JP:4584
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology